Cargando…

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer

SIMPLE SUMMARY: Immunotherapy has revolutionized cancer treatment and has been integrated in the treatment algorithm of metastatic head and neck cancer. Despite robust clinical efficacy shown in clinical trials, only a minority of patients derive benefit from immunotherapy. Indeed, an important para...

Descripción completa

Detalles Bibliográficos
Autores principales:	Economopoulou, Panagiota, Kotsantis, Ioannis, Psyrri, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696050/ https://www.ncbi.nlm.nih.gov/pubmed/33203092 http://dx.doi.org/10.3390/cancers12113377

Ejemplares similares

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Special Issue about Head and Neck Cancers: HPV Positive Cancers
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Editorial: Women in head and neck cancer 2021
por: Economopoulou, Panagiota, et al.
Publicado: (2022)

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

The Role of B Cells in Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma
por: Spathas, Nikolaos, et al.
Publicado: (2018)

Lymph Node Ratio as a Prognostic Factor in Neck Dissection in Oral Cancer Patients: A Systematic Review and Meta-Analysis
por: Gartagani, Zoi, et al.
Publicado: (2022)

Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy
por: Strati, Areti, et al.
Publicado: (2023)

The DNA damage response network in the treatment of head and neck squamous cell carcinoma
por: Psyrri, A., et al.
Publicado: (2021)

Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature
por: Tsavaris, Onoufrios, et al.
Publicado: (2018)

Medical management of gastric cancer: a 2017 update
por: Charalampakis, Nikolaos, et al.
Publicado: (2017)

Tyrosine kinase inhibitors in sarcoma treatment
por: Kyriazoglou, Anastasios, et al.
Publicado: (2022)

Systematic Review of Recurrent Osteosarcoma Systemic Therapy
por: Gazouli, Ioanna, et al.
Publicado: (2021)

Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV(+) “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma
por: Gavrielatou, Niki, et al.
Publicado: (2023)

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
por: Moutafi, Myrto, et al.
Publicado: (2023)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment
por: Vagia, Elena, et al.
Publicado: (2015)

Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
por: Economopoulou, Panagiota, et al.
Publicado: (2013)

Immune Cells in Head-and-Neck Tumor Microenvironments
por: Jumaniyazova, Enar, et al.
Publicado: (2022)

929TiP HERODOTUS: Head and neck cancers international COVID-19 collaboration: An international registry on head and neck cancer with COVID-19
por: Psyrri, A., et al.
Publicado: (2021)

Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment
por: Nisar, Sabah, et al.
Publicado: (2021)

Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literature
por: Kotsantis, Ioannis, et al.
Publicado: (2016)

T cell effects and mechanisms in immunotherapy of head and neck tumors
por: Xiang, Yizhen, et al.
Publicado: (2023)

Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers
por: Kokkali, Stefania, et al.
Publicado: (2023)

Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
por: Peng, Shaojun, et al.
Publicado: (2021)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
por: Albers, A. E., et al.
Publicado: (2010)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

Diagnostically Challenging Subtypes of Invasive Lobular Carcinomas: How to Avoid Potential Diagnostic Pitfalls
por: Koufopoulos, Nektarios, et al.
Publicado: (2022)

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
por: Benavente, Sergi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1r3c0rr95gkrllscd1jlt588mg